MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Syringas, M.
Right arrow Articles by Bonnet, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Syringas, M.
Right arrow Articles by Bonnet, J.-J.

Vol. 58, Issue 6, 1404-1411, December 2000

Structural Domains of Chimeric Dopamine-Noradrenaline Human Transporters Involved in the Na+- and Clminus -Dependence of Dopamine Transport

Maria Syringas, François Janin, Sana Mezghanni, Bruno Giros, Jean Costentin, and Jean-Jacques Bonnet

Unité Propre de Recherche de l'Enseignement Supérieur, Centre National de la Recherche Scientifique 6036, Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23, Unité de Formation et de Recherche de Médecine Pharmacie, Rouen, France (M.S., F.J., S.M., J.C., J.-J.B.), and Institut National de la Santé et de la Recherche Médicale U513, Créteil, France (B.G.)

Catecholamine transporters constitute the biological targets for several important drugs, including antidepressants, cocaine, and related compounds. Some information exists about discrete domains of these transporters that are involved in substrate translocation and uptake blockade, but delineation of domains mediating the ionic dependence of the transport remains to be defined. In the present study, human neuronal transporters for dopamine and noradrenaline (hDAT and hNET) and a series of six functional chimeras were transiently expressed in LLC-PK1 cells. Substitution of Cl- by isethionate reveals that cassette IV (i.e., the region of the transporter encompassing transmembrane domain 9 through the COOH terminal) plays an important role in the Cl-- dependence of the uptake. Substitutions of Na+ and NaCl by Tris+ and sucrose, respectively, demonstrate that three different segments scattered across the transporter are involved in the Na+- dependence of the transport activity: cassette I (i.e., the region from the amino terminus through the first two transmembrane domains), cassette IV, and junction between transmembrane domains 3 to 5 and 6 to 8. Results of the present work also suggest that the use of Tris+ as a substitute for Na+ results in a biased estimate of the Hill number value for hDAT. This study provides useful clues for identifying specific residues involved in the uptake function of the catecholamine transporters.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. J. Bryan-Lluka, H. Bonisch, and R. J. Lewis
{chi}-Conopeptide MrIA Partially Overlaps Desipramine and Cocaine Binding Sites on the Human Norepinephrine Transporter
J. Biol. Chem., October 10, 2003; 278(41): 40324 - 40329.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics